CHEK2 and colorectal cancer: Over time RCC may become recognised as a complication of some CSGs that primarily predispose to other phenotypes, for example, recent reports have suggested that CHEK2 mutations (primarily associated with predisposition to breast, prostate and colorectal cancers) are associated with a two-fold increased risk of RCC [35].